Cost-Effectiveness of Erenumab for the Preventive Treatment of Migraine in Patients with Prior Treatment Failures in Sweden
R Mahon, A Lang, Pamela Vo, Jasper Huels, Philip Cooney, Andriy Danyliv, Umakanth Vudumula, Sreelatha Vadapalle, Farooq Maniyar, Peter J. Goadsby
Topics & Concepts
MigraineMedicinePopulationQuality-adjusted life yearHealth economicsClinical trialPlaceboHealth careRandomized controlled trialCost effectivenessPhysical therapyPediatricsPublic healthAlternative medicineInternal medicineEnvironmental healthEconomicsNursingPathologyRisk analysis (engineering)Economic growthMigraine and Headache StudiesTraumatic Brain Injury ResearchNeurological Complications and Syndromes